Clinical trial
Targeting Steroid Resistance During Acute Exacerbations of Chronic Obstructive Pulmonary Disease With Respiratory Failure - The AECOPD Resistance Study
NCT03680495 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Targeting Steroid Resistance During Acute Exacerbations of Chronic Obstructive Pulmonary Disease With Respiratory Failure - The AECOPD Resistance Study
- Lead sponsor
- University of Colorado, Denver
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- July 21, 2017
- Completion date
- January 31, 2021
- Enrollment
- 46 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
copd, copd exacerbation, copd exacerbation acute, emphysema or copd, respiratory failure, ventilatory failure